Further characterization revealed that Compound 3 (Table 1) reduced Miro1 levels after mitochondrial depolarization in patient-derived PD fibroblasts, showing a neuroprotective effect, both in vivo and in vitro models (128). Here, RHOT1 is linked to Parkinson disease.